Pakistan clears pharma group but puts industry on notice
Pakistan’s competition watchdog has set aside a prima facie finding that a pharmaceutical organisation violated cartel rules, but warned the entire sector against engaging in anticompetitive behaviour.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.